MyAverix Finance
F · Healthcare
ABBISKO CAYMAN DL-00001 (8ZD)
Biotechnology
ABBISKO CAYMAN DL-00001 (8ZD) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 8ZD
ABBISKO CAYMAN DL-00001 (8ZD) — FAQ
What is 8ZD's P/E ratio?
The price-to-earnings (P/E) ratio for ABBISKO CAYMAN DL-00001 (8ZD) is 25.00 (data as of 2026-05-23).
Does ABBISKO CAYMAN DL-00001 pay a dividend?
Dividend yield is not available in the current snapshot for ABBISKO CAYMAN DL-00001 (8ZD). Check the MyAverix Finance app for the latest dividend data.
What sector is ABBISKO CAYMAN DL-00001 in?
ABBISKO CAYMAN DL-00001 (8ZD) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 8ZD listed on?
8ZD is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.